Diabetes Prevention With Lifestyle Intervention and Metformin Escalation

NCT03258723 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

114

Enrollment

OTHER

Sponsor class

Stopped COVID-19 led to changes in study design and an early end to data collection.

Conditions

Diabetes

Interventions

BEHAVIORAL: Lifestyle Intervention
DRUG: Metformin

Sponsor

Yale University

Collaborators

[object Object]
[object Object]